ABBOTT LABORATORIES 4
4 · ABBOTT LABORATORIES · Filed Feb 20, 2013
Insider Transaction Report
Form 4
Simhambhatla Murthy V
Senior Vice President
Transactions
- Tax Payment
Common shares without par value
2013-02-17$35.08/sh−442$15,505→ 32,127 total - Sale
Common shares without par value
2013-02-19$34.78/sh−402$13,983→ 31,135 total - Award
Common shares without par value
2013-02-15+23,000→ 32,569 total - Tax Payment
Common shares without par value
2013-02-18$35.08/sh−314$11,015→ 31,813 total - Tax Payment
Common shares without par value
2013-02-19$35.08/sh−276$9,682→ 31,537 total - Award
Option (right to buy)
2013-02-15+119,700→ 119,700 totalExercise: $34.94From: 2014-02-15Exp: 2023-02-14→ Common shares (119,700 underlying)
Footnotes (2)
- [F1]These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
- [F2]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 39,900 on 2/15/2014, 39,900 on 2/15/2015, and 39,900 on 2/15/2016.